Related Experiment Video
Updated: Jul 20, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Diagnosing migraine in the pediatric population
Paul Winner1, Andrew D Hershey
1Palm Beach Headache Center, Premiere Research Institute at Palm Beach Neurology, West Palm Beach, FL 33407, USA. eneuro@aol.com
Current Pain and Headache Reports
|September 2, 2006
Summary
Pediatric migraine is often missed and undertreated. Revised diagnostic criteria aim to improve accuracy for childhood migraine diagnosis and management.
Area of Science:
- Neurology
- Pediatrics
- Headache Medicine
Background:
- Migraine diagnosis in children is frequently inaccurate, leading to delayed or inadequate treatment.
- Underdiagnosis and undertreatment of pediatric migraine are significant clinical challenges.
- Recent updates to headache classification systems offer potential for improved diagnostic precision.
Purpose of the Study:
- To review practical diagnostic challenges of migraine in pediatric patients.
- To highlight the impact of revised diagnostic criteria on pediatric migraine identification.
- To provide insights for clinicians managing childhood headaches.
Main Methods:
- Review of current literature on pediatric migraine diagnosis.
- Analysis of the revised International Classification of Headache Disorders (ICHD) criteria.
- Discussion of clinical scenarios and diagnostic pitfalls in children.
Main Results:
- The revised ICHD criteria offer a framework for more accurate pediatric migraine diagnosis.
- Specific diagnostic challenges in children, such as symptom variability, are addressed.
- Improved diagnostic accuracy can facilitate timely and appropriate treatment initiation.
Conclusions:
- Accurate diagnosis of pediatric migraine is crucial for effective management.
- The updated classification system is a valuable tool for improving diagnostic rates.
- Addressing practical diagnostic issues is essential to reduce the burden of migraine in children.
Related Concept Videos
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...